PharmaLogic Holdings Corp.

PharmaLogic Holdings Corp. is a North American contract development and manufacturing organisation (CDMO) specialising in radiopharmaceuticals for diagnostic imaging and therapeutic applications.

Founded in 1993 and headquartered in Boca Raton, Florida, PharmaLogic Holdings Corp. is a privately held CDMO with a focus on the development, manufacturing, and commercialisation of novel radiopharmaceuticals. The company operates an extensive network of radiopharmacies and production facilities across the United States and Canada, enabling it to deliver advanced molecular imaging and theranostic solutions to healthcare providers. With decades of expertise in drug development, PharmaLogic addresses the dynamic challenges of the molecular imaging and theranostics industry, bringing life-changing radiopharmaceuticals from discovery through to commercialisation.

Key Products and Services:

CDMO Services: Comprehensive support from preclinical development to commercial launch, including regulatory filing and quality assurance frameworks for investigational trials and new drug applications.

Radiopharmacy Solutions: A network of SPECT and PET radiopharmacies providing state-of-the-art imaging technology and expertise to healthcare providers.

Manufacturing: State-of-the-art infrastructure investments ensuring access to advanced tools for drug development, manufacturing, and distribution.

Distribution: An extensive network of radiopharmacies and manufacturing facilities across North America, providing broad reach for radiopharmaceutical products.

Clinical Use: Expertise in bringing the latest advances in care to patients, supporting the clinical application of radiopharmaceuticals.

PharmaLogic's commitment to advancing radiopharmaceutical technology is evident in its strategic investments and partnerships aimed at enhancing patient access to innovative diagnostics and therapies. Through its integrated services and extensive network, the company continues to play a pivotal role in the development and delivery of life-changing radiopharmaceuticals across North America.